SMA — where it's treated in the network
Most families arrive with the SMA diagnosis already confirmed and a drug already prescribed — nusinersen (Spinraza), Zolgensma or risdiplam (Evrysdi) — looking for who will take on the rehabilitation side. A network case manager will help compare clinics by SMA type (I–IV), the child's age, respiratory function and travel logistics, then schedule the course around the injection calendar.
Where it is treated in our network
4 clinics in our network offer different approaches to this diagnosis.
- Yuncheng, China
People's Hospital — Yuncheng
Surgical support for severe scoliosis with indication for spinal fusion (usually Cobb >50° by end of growth): on-site operating block + post-op rehabilitation starting in the first days after surgery. Tight surgery-physiotherapy integration.
Visit clinic site - Huizhou, China
Neurolife — Huizhou
Long-running program for all SMA types: specialized exercise therapy without motor neuron overload, respiratory gymnastics with BiPAP/Cough Assist training, occupational therapy with assistive technology selection, TCM for immunity support. Coordination with the home neurologist on nusinersen/Zolgensma/Evrysdi protocols.
Visit clinic site - Shangrao, China
Hansi — Stem Cells
Experimental autologous cell therapy (MSC) for selected SMA candidates — adjunct to disease-modifying therapy with Spinraza/Zolgensma. 5-stage protocol with consultation+screening to determine response. Only after coordination with the treating neurologist.
Visit clinic site - Tashkent, Uzbekistan
Neurolife — Tashkent
Support program between visits to Chinese clinics: exercise therapy, respiratory gymnastics, occupational therapy. Without travelling to China — for CIS families. Rehabilitologist follow-ups, coordination with parents on the course schedule in core network clinics.
Visit clinic site
What is Spinal Muscular Atrophy (SMA)?
Spinal muscular atrophy (SMA) is an inherited neuromuscular disease in which motor neurons in the anterior horns of the spinal cord gradually die, and the signal from the brain to the muscles no longer arrives in full. The cause is a fault in the SMN1 gene on chromosome 5; severity depends on the SMN2 backup gene copy number. ICD-10 codes it as G12.0 (SMA type I) across G12.0–G12.9. It occurs in 1 of every 6,000–10,000 newborns.
Families usually reach the network case manager with the SMA diagnosis already confirmed and a drug already prescribed — nusinersen (Spinraza), Zolgensma or risdiplam (Evrysdi) — looking for who will take on the rehabilitation side. The case manager will help compare clinics by SMA type (I–IV), the child's age and respiratory function. Details on causes, symptoms, diagnostics and the rehabilitation program are in the expandable blocks below.
Frequently asked questions about Spinal Muscular Atrophy (SMA)
Is rehabilitation suitable for SMA type I?
Can rehabilitation be combined with Spinraza/Zolgensma?
Which network clinic suits SMA with severe scoliosis?
How often are rehabilitation courses needed?
Other directions in this category
Other diagnoses in this category — pick the most relevant one.
Talk to a network coordinator
The coordinator reviews your documents and suggests matching clinics. We reply on Telegram and WhatsApp within an hour on workdays.